SCHEMBL30508263

SCHEMBL30508263

Nc1ncc(Br)cc1C(=O)NC1CCOCC1

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ PIK3C3 Q8NEB9 2/20 0.56
▸ BMPR1B O00238 10/20 0.53
▸ BMPR1A P36894 10/20 0.53
▸ TGFBR1 P36897 10/20 0.53
▸ ACVRL1 P37023 10/20 0.53
▸ ACVR1 Q04771 10/20 0.53
▸ OPRK1 P41145 1/20 0.47
▸ CNR2 P34972 2/20 0.46
▸ ATR Q13535 2/20 0.46
▸ SMYD3 Q9H7B4 1/20 0.46
▸ CSNK2A2 P19784 1/20 0.46
▸ CSNK2A1 P68400 1/20 0.46
▸ CNR1 P21554 1/20 0.44
▸ HPGDS O60760 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29041999 1.00 PIK3C3 (0.56) PIK3C3BMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL22558893 0.92 PIK3C3 (0.49) PIK3C3BMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL22585726 0.92 PIK3C3 (0.49) PIK3C3BMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL3059096 0.90 SMYD3 (0.55) PIK3C3BMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL30964448 0.90 SMYD3 (0.55) PIK3C3BMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL22558810 0.88 CNR2 (0.55) PIK3C3BMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL20995270 0.85 BMPR1B (0.62) PIK3C3BMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL20995120 0.85 BMPR1B (0.62) PIK3C3BMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL20995122 0.85 BMPR1B (0.62) PIK3C3BMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL29042024 0.82 PIK3C3 (0.54) PIK3C3BMPR1BBMPR1ATGFBR1ACVRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116478145-B ALK2 kinase inhibitors 杭州邦顺制药有限公司 2024-02-02 — — CN disclosed
CN-116478145-A ALK2 kinase inhibitors 杭州邦顺制药有限公司 2023-07-25 — — CN disclosed
Send feedback